Achillion slides on sovaprevir hold

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) slid $2.10 (25%) to $6.26 on Tuesday after announcing late Monday that FDA placed a partial clinical hold on sovaprevir. The hold was based on a Phase I dr...